Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Sinovac Product Pipeline News 2016-10-19 18:00
LUI Che Woo Prize - Prize for World Civilisation Inaugural Prize Presentation Ceremony 2016-10-04 00:15
Merck Joins DiViNe Consortium to Address Low Yields, High Costs of Vaccine Purification Processes 2016-09-14 20:00
EpiVax To Advance Development Of Vaccine Against Stealth Flu Virus With New Funding 2016-09-13 03:24
Merck Launches New Gene Editing Technology to Engineer Virus Resistant CHO Cell Lines 2016-09-08 20:00
Broad-Spectrum Antiviral Drug HSRx 431(TM) Tests Effective Against Zika Virus 2016-09-06 21:00
Experts at World Congress of Internal Medicines Reinforce Importance of BETADINE(R) in Disease Prevention, Infection Control and Oral Mucositis Treatment 2016-08-24 19:03
bioLytical Laboratories Announces Patent Filings in U.S. for Zika Detection Assays 2016-08-19 21:00
ViiV Healthcare Launches Phase III Programme Evaluating a Two-drug Regimen Combining Dolutegravir and Lamivudine for HIV-1 Treatment 2016-08-16 21:14
Dengue Immunization Public Program in Parana State of Brazil Set To Achieve WHO 2020 Ambition 2016-08-13 19:46
LUI Che Woo Prize - Prize for World Civilisation Announces First Laureates 2016-07-27 04:53
ARIA Study Shows Superior Efficacy of Triumeq(R) for Treatment-naive Women Living with HIV 2016-07-18 20:29
RayVio Deep UV LEDs Show Strong Disinfection Performance in Test 2016-07-07 08:00
KT CEO Hwang Chang-Gyu Delivers Speech at UN Global Compact: "Join hands with the UN to prevent the spread of global diseases" 2016-06-27 22:27
Sanofi Pasteur Dengue Vaccine Approved in Costa Rica 2016-06-23 11:05
FDA Approves PaxVax to Manufacture Vaxchora™ (Oral Cholera Vaccine) at SynCo Bio Partners 2016-06-20 15:00
ADVA launches Dengue Mission Buzz Barometer tool to boost critical dengue prevention awareness and preparedness amongst ASEAN Community 2016-06-15 10:00
Innovative Diagnostics Awarded Unprecedented Westgard Sigma Certification in Singapore 2016-06-08 09:00
Frontier Biotech's Long-acting HIV-1 Fusion Inhibitor Albuvirtide Meets 48-Week Primary Objective: Interim Results of a Phase 3 Trial 2016-06-06 14:03
Ennaid Therapeutics Invited To Participate In The International Society for Neglected Tropical Diseases: Discovery, Development, Diagnostics (ISNTD d3) Conference In London, UK 2016-05-24 01:34
1 84 85 86 87 88 93